XML 39 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Net revenues (Tables)
 9 Months Ended
Sep. 27, 2020
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
The following table disaggregates revenue by global product category for the three and nine months ended September 27, 2020 and September 29, 2019.
Three Months EndedNine Months Ended
September 27, 2020September 29, 2019September 27, 2020September 29, 2019
(Dollars in thousands)
Vascular access$160,052 $148,681 $475,252 $446,225 
Anesthesia75,647 87,123 216,204 253,098 
Interventional93,187 106,883 275,704 314,852 
Surgical82,223 92,621 224,928 274,911 
Interventional urology81,773 73,629 196,114 201,312 
OEM49,399 55,444 168,618 166,110 
Other (1)
86,020 83,938 269,157 257,902 
Net revenues (2)
$628,301 $648,319 $1,825,977 $1,914,410 
(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).
(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.